Omega Therapeutics, Inc. (34)

Browse by Contract Category

Contracts

Employment Agreement by and between Joshua Reed and the Registrant, dated April 28, 2022 (Filed With SEC on May 4, 2022)
Amendment to Shared Space Agreement between Omega Therapeutics, Inc. and Senda Biosciences, Inc., dated January 31, 2022 (Filed With SEC on March 10, 2022)
Lease Agreement between Omega Therapeutics, Inc. and ARE-MA Region No, 94, LLC (Filed With SEC on March 10, 2022)
Description of Capital Stock (Filed With SEC on March 10, 2022)
Development and Option Agreement between Acuitas Therapeutics, Inc. and the Registrant, dated October 5, 2020, as amended (Filed With SEC on July 26, 2021)
License Agreement between Flagship Pioneering Innovations V, Inc. and the Registrant, dated March 12, 2019 (Filed With SEC on July 9, 2021)
Employment Agreement by and between Ling Zeng and the Registrant, dated March 18, 2022 (Filed With SEC on May 4, 2022)
Employment Agreement by and between Kevin McManus and the Registrant, dated February 3, 2022 (Filed With SEC on May 4, 2022)
Amendment to Consulting Agreement by and between Richard A. Young and the Registrant, dated October 29, 2021 (Filed With SEC on March 10, 2022)
Consulting Agreement by and between Richard A. Young and the Registrant, dated November 7, 2016 (Filed With SEC on March 10, 2022)
Employment Agreement by and between Yan Moore and the Registrant, dated December 12, 2021 (Filed With SEC on March 10, 2022)
Fourth Amendment to Loan and Security Agreement, dated December 20, 2021 (Filed With SEC on December 21, 2021)
Lease Agreement between BMR-325 Vassar Street LLC and the Registrant, dated November 30, 2017 (Filed With SEC on July 26, 2021)
Employment Agreement between Roger Sawhney and the Registrant, dated July 24, 2021 (Filed With SEC on July 26, 2021)
Employment Agreement between Thomas McCauley and the Registrant, dated July 24, 2021 (Filed With SEC on July 26, 2021)
Employment Agreement between Mahesh Karande and the Registrant, dated July 25, 2021 (Filed With SEC on July 26, 2021)
Loan and Security Agreement between Pacific Western Bank (n/k/a PacWest Bancorp) and the Registrant, dated March 9, 2018, as amended on September 30, 2019, January 22, 2020 and... (Filed With SEC on July 26, 2021)
Shared Space Arrangement between Kintai Therapeutics, Inc. (n/k/a Senda Biosciences, Inc.) and the Registrant, dated July 13, 2020 (Filed With SEC on July 26, 2021)
Non-Employee Director Compensation Program (Filed With SEC on July 26, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on July 26, 2021)
2021 Incentive Award Plan and form of agreements thereunder (Filed With SEC on July 26, 2021)
Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on July 26, 2021)
Form of Underwriting Agreement (Filed With SEC on July 26, 2021)
Form of Indemnification Agreement for Directors and Officers (Filed With SEC on July 26, 2021)
Amended and Restated Warrant to Purchase Stock issued to PacWest Bancorp, dated September 30, 2019, to purchase Series A preferred stock (Filed With SEC on July 9, 2021)
Offer Letter between Roger Sawhney and the Registrant, dated March 25, 2020 (Filed With SEC on July 9, 2021)
2017 Equity Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on July 9, 2021)
Offer Letter between Mahesh Karande and the Registrant, dated March 2, 2019 (Filed With SEC on July 9, 2021)
Offer Letter between Tom McCauley and the Registrant, dated July 10, 2019 (Filed With SEC on July 9, 2021)
Development and Option Agreement between Acuitas Therapeutics, Inc. and the Registrant, dated October 5, 2020, as amended (Filed With SEC on July 9, 2021)
Exclusive License Agreement between the Whitehead Institute for Biomedical Research and the Registrant, dated May 22, 2019 (Filed With SEC on July 9, 2021)
Co-Exclusive License Agreement between the Whitehead Institute for Biomedical Research and the Registrant, dated May 22, 2019 (Filed With SEC on July 9, 2021)
Non-Exclusive License Agreement between Acuitas Therapeutics, Inc. and the Registrant, dated March 22, 2021 (Filed With SEC on July 9, 2021)
Amended and Restated Investors Rights Agreement, dated March 4, 2021 (Filed With SEC on July 9, 2021)